Global Pulse

分类： health

  • Thumbay University Hospital performs its first advanced heart bypass surgery

    Thumbay University Hospital performs its first advanced heart bypass surgery

    Thumbay University Hospital has marked a transformative advancement in cardiac care with the successful execution of its inaugural coronary artery bypass grafting (CABG) surgery. This pioneering procedure establishes the hospital’s capability to deliver sophisticated cardiac surgical services within its academic medical environment.

    The landmark operation was performed on Syed Omer, a 51-year-old patient presenting with severe ischemic coronary artery disease complicated by critical left main coronary artery stenosis—a high-risk condition that severely limits cardiac blood flow. The patient’s concurrent diabetes mellitus necessitated meticulous perioperative management and specialized cardiac expertise.

    Employing the technically demanding off-pump (beating heart) technique, the surgical team conducted a double-vessel bypass without utilizing a heart-lung machine. This innovative approach minimizes physiological stress during surgery and is correlated with accelerated recovery timelines, reduced complication rates, and enhanced clinical outcomes for appropriately selected patients.

    Under the leadership of Dr. Khaled Farrag, Consultant Cardiothoracic Surgeon, the specialized cardiac team successfully implanted two grafts to circumvent blocked coronary arteries, effectively restoring optimal blood circulation to the heart muscle. The patient has been discharged, resumed normal activities, and continues to receive remote medical monitoring.

    Akbar Moideen Thumbay, Vice President of the Healthcare Division at Thumbay Group, characterized the achievement as: “This inaugural bypass surgery transcends mere medical procedure—it heralds a new epoch of advanced cardiac care within our academic healthcare network. This milestone demonstrates our clinical proficiency, infrastructural robustness, and enduring dedication to delivering complex, life-preserving treatments accessible to the community. It reaffirms our conviction that university hospitals must pioneer both educational and clinical excellence.”

    The successful operation validates the hospital’s operational preparedness for managing intricate cardiac conditions, including high-risk coronary artery disease. The cardiac program is supported by state-of-the-art surgical facilities, intensive care units, comprehensive diagnostic capabilities, and fully integrated emergency and rehabilitation services.

    This development ensures patient access to advanced cardiac surgery within an academic medical institution supported by evidence-based treatment protocols, continuous scholarly oversight, and multidisciplinary medical expertise.

  • Researchers uncover key to overcoming drug resistance in breast cancer

    Researchers uncover key to overcoming drug resistance in breast cancer

    A groundbreaking study led by Chinese scientists has identified a previously unknown mechanism behind treatment resistance in one of the most aggressive forms of breast cancer. Published in the prestigious journal Cell, the research reveals how sensory nerves within tumors actively block immunotherapy effectiveness in triple-negative breast cancer (TNBC) patients.

    The research team from Fudan University Shanghai Cancer Center and the Institute for Translational Brain Research made a paradigm-shifting discovery by examining the tumor microenvironment rather than focusing exclusively on cancer cells themselves. Their analysis of 360 clinical samples demonstrated that tumors with significant sensory nerve infiltration consistently showed the poorest patient outcomes.

    According to lead researcher Dr. Shao Zhimin, director of general surgery at the center, these sensory nerves—typically responsible for transmitting touch and pain sensations—effectively prevent immune cells from penetrating the core regions of tumors. The study details how cancer cells communicate with these nerves, triggering nearby cells to produce dense collagen barriers that physically block immunotherapies from reaching their targets.

    The research offers immediate clinical implications through the experimental use of rimegepant, an already-approved migraine medication. In animal models, this drug successfully disrupted nerve signaling pathways, simultaneously slowing cancer progression and restoring immunotherapy effectiveness. Because rimegepant has established safety profiles and regulatory approval, researchers believe these findings could rapidly transition to human clinical trials.

    Dr. Jiang Yizhou, another lead expert on the project, emphasized that the collagen barrier acts as a physical wall protecting cancer cells from immune attack. The study fundamentally changes how scientists approach cancer treatment by demonstrating the critical integration between nervous and immune systems in tumor development and treatment resistance.

    This discovery represents a significant advancement in oncology, particularly for TNBC patients who account for approximately 20% of breast cancer cases and face limited treatment options due to the cancer’s aggressive nature and tendency to metastasize rapidly.

  • New therapy uses gene-edited pig liver

    New therapy uses gene-edited pig liver

    In a groundbreaking medical achievement, Chinese physicians at Xijing Hospital in Xi’an have successfully administered a novel treatment to a liver failure patient using a genetically modified pig liver in an extracorporeal perfusion procedure. The patient has maintained stable vital signs for over two days following this pioneering intervention, marking a significant milestone in xenotransplantation research.

    The innovative technique involves connecting the patient’s circulatory system to a porcine liver housed within an advanced mechanical device outside the body. This external organ support system, linked via the patient’s femoral vein, performed critical hepatic functions including detoxification, metabolic processing, and synthesis throughout the 66-hour treatment duration while the patient’s native liver remained intact.

    Medical researchers employed a specially engineered pig liver featuring six strategic genetic modifications to minimize rejection risks. The sophisticated perfusion apparatus maintained precise environmental controls for temperature, pressure, and oxygenation throughout the procedure. Following disconnection, physicians observed substantial and sustained improvement in the patient’s liver function indicators.

    Professor Wang Lin, Director of Hepatobiliary Surgery at Xijing Hospital, characterized the 50-hour post-procedure stability as “satisfactory” while acknowledging that longer-term assessment remains necessary. The technique offers a minimally invasive alternative to conventional transplantation, resembling dialysis methodology while reducing dependency on intensive immunosuppressive regimens.

    This development addresses China’s critical organ shortage crisis, where current data indicates over 400 million citizens live with liver conditions and approximately 181,000 patients await transplants amid a severe supply-demand imbalance. The treatment provides temporary hepatic support for transplant candidates awaiting donor organs, leveraging China’s established infrastructure for gene-edited pig cultivation and perfusion technology.

    The pioneering procedure was conducted under the leadership of Academician Dou Kefeng of the Chinese Academy of Sciences, with collaborative support from multiple medical institutions and ClonOrgan Biotechnology, a frontrunner in xenotransplantation research. Dou has hailed this success as a landmark advancement in clinical xenotransplantation with substantial potential for broader application.

  • UAE to combine traditional Emirati medicine with healthcare, says health minister

    UAE to combine traditional Emirati medicine with healthcare, says health minister

    The United Arab Emirates is embarking on a groundbreaking healthcare transformation by formally integrating traditional Emirati healing practices with conventional medical treatments. Health Minister Ahmed Al Sayegh announced this strategic initiative during the World Governments Summit in Dubai, marking a significant shift in the nation’s approach to wellness and disease prevention.

    Minister Al Sayegh, appointed to his position in September 2025, shared personal reflections on the effectiveness of traditional medicine, noting that approximately 70% of his childhood treatments involved these ancestral practices. He emphasized that these methods contributed significantly to building robust health among earlier generations of Emiratis.

    The newly formulated approach, termed ‘integrative medicine,’ represents a comprehensive healthcare model that combines conventional medical treatments with lifestyle modifications while addressing mental and spiritual wellbeing alongside physical health. This methodology aims to move traditional practices from the periphery to the core of the UAE’s healthcare prevention strategies.

    To ensure patient safety and treatment efficacy, the Ministry of Health and Prevention will establish a robust legislative framework governing the implementation of these traditional practices. The minister clarified that while science remains paramount in addressing critical health challenges—evidenced by the dramatic reduction in child and maternal mortality rates over recent decades—traditional knowledge offers valuable complementary benefits.

    Minister Al Sayegh highlighted specific examples, including holistic care protocols for pregnant women that incorporate traditional dietary recommendations, specialized exercises, and indigenous wellness practices similar to yoga. He expressed concern that these valuable traditional skills are gradually being lost and emphasized the ministry’s role in preserving this cultural heritage through structured training programs that combine ancestral wisdom with scientific validation.

    This national initiative builds upon the foundation established by the UAE Integrative Medicine Council (UAEIMC), formed in September 2025 under the leadership of Sheikha Salama bint Tahnoon bin Mohammed Al Nahyan. The council promotes a multidisciplinary approach that safely integrates modern, traditional, and complementary medical practices.

    The UAE’s commitment to integrative medicine will be further demonstrated later this month when the country hosts the AYUSH Conference & Exhibition, bringing together wellness brands, clinics, and hospital representatives to showcase ancient medical traditions and their contemporary applications.

  • US healthcare needs fixing, but there’s no agreement on how to do it

    US healthcare needs fixing, but there’s no agreement on how to do it

    The American healthcare system continues to generate devastating financial consequences for millions of citizens, exemplified by the case of Jeff King, a 66-year-old former pastor from Lawrence, Kansas. Following a routine procedure to correct his irregular heart rhythm, King received an astonishing $160,000 medical bill that threatened to bankrupt him. Despite having a cost-sharing alternative plan, his coverage excluded the treatment entirely.

    King’s predicament reflects a national crisis where approximately 100 million Americans—roughly 40% of the population—struggle with medical and dental debt. The United States maintains the world’s most expensive healthcare system, with projected expenditures reaching $5.9 trillion in 2026 according to Centers for Medicare and Medicaid Services data. Paradoxically, despite per capita healthcare spending that doubles that of comparable wealthy nations, America demonstrates lower life expectancy rates according to research from nonprofit KFF.

    The system’s failures have generated widespread public frustration, sometimes with tragic consequences. In December 2024, UnitedHealthCare CEO Brian Thompson was fatally shot in Manhattan by Luigi Mangione, who subsequently gained support from protesters viewing him as a folk hero opposing the healthcare establishment. While a judge recently dismissed federal firearms murder charges against Mangione, the incident highlights the intense emotions surrounding healthcare affordability.

    Political solutions remain elusive despite bipartisan recognition of systemic problems. Former President Donald Trump recently proposed his “Great Healthcare Plan” featuring direct payments to citizens for insurance costs and eliminating “kickbacks” to middlemen. However, experts note the plan lacks critical details regarding funding mechanisms and implementation strategies.

    The Affordable Care Act (ACA) implemented under President Obama significantly expanded coverage but created a patchwork system that falls short of universal healthcare. A decade after full implementation, frustrations persist as approximately 20% of privately insured Americans reported claim denials for doctor-recommended care in 2023.

    The expiration of COVID-era subsidies has exacerbated the crisis, with millions facing dramatic premium increases. Stacy Cox, a Utah-based photographer with high breast cancer risk, saw her insurance costs quadruple from $500 to $2,100 monthly, forcing her to abandon comprehensive coverage. Similarly, Mike Short, a Tennessee graphic artist with preexisting medical debt, now risks financial ruin from potential health complications.

    Structural complexities involving multiple overlapping systems—Medicare, Medicaid, employer-sponsored insurance, and veteran’s healthcare—create bureaucratic inefficiencies and confusion. Health policy experts advocate for system consolidation and stronger price negotiation mechanisms for pharmaceuticals.

    While some states have implemented local solutions such as banning medical debt from credit reports and providing separate subsidies, the federal government struggles to achieve consensus. As healthcare companies have tripled profits over two decades and distributed $2.6 trillion to shareholders since 2001, ordinary Americans continue facing impossible choices between financial stability and essential medical care.

  • UK says infant formula contamination may have affected 36 babies

    UK says infant formula contamination may have affected 36 babies

    British health authorities have confirmed 36 probable cases of infant poisoning connected to contaminated formula products, sparking nationwide concern over food safety standards. The UK Health Security Agency (UKHSA) disclosed on Thursday that these cases exhibit symptoms consistent with toxin exposure from affected batches of nutritional products.

    The contamination crisis began on January 6th when Nestle initiated a massive European recall of several infant nutrition lines, including SMA, BEBA and NAN formulas, following the discovery of potential toxin contamination. The compromised products were found to contain substances capable of inducing severe nausea and vomiting in infants. Subsequently, Danone expanded the recall effort two weeks later by withdrawing one batch of its Aptamil infant formula.

    UKHSA officials indicated that the widespread distribution of these products prior to their removal from shelves made additional cases inevitable. Despite issuing urgent alerts to healthcare facilities nationwide, the agency acknowledged the challenge in containing exposure given the products’ previous market penetration.

    Notably, current surveillance data reveals no abnormal increases in vomiting reports among children under one year old compared to seasonal norms. However, UKHSA maintains heightened vigilance through continuous monitoring of public health indicators. The agency emphasizes that while the risk has been substantially reduced through recall actions, healthcare providers should remain alert for potential late-presenting cases.

    The incident has triggered rigorous quality control reassessments within the infant nutrition industry and prompted calls for strengthened food safety protocols across European markets.

  • Experts warn against drinking raw milk after New Mexico baby’s listeria death

    Experts warn against drinking raw milk after New Mexico baby’s listeria death

    A tragic infant death in New Mexico has triggered urgent health warnings from medical experts regarding the consumption of unpasteurized raw milk. Health authorities confirmed a newborn succumbed to a listeria infection that was likely transmitted when the mother consumed raw dairy during pregnancy. This fatal case has ignited renewed concerns about the dangerous trend of consuming untreated dairy products.

    The New Mexico Department of Health emphasized that raw milk carries significant pathogen risks including bird flu, brucella, tuberculosis, salmonella, campylobacter, cryptosporidium, and E. coli. Unlike pasteurized milk, which undergoes a heating process to eliminate dangerous bacteria, raw milk comes directly from animals without any pathogen-elimination treatment. Listeria poses particular danger to pregnant women as it can cross the placental barrier, with neonatal infections carrying a 20-30% mortality rate.

    This safety alert emerges alongside developments at Ballerina Farm, a prominent influencer-owned company with over 10 million social media followers, which recently paused raw milk sales following routine testing that revealed health violations. The company’s owner, Hannah Neeleman, had previously promoted raw milk as ‘liquid gold’ on Instagram, claiming skincare benefits and stating her family drinks directly from the cow.

    The raw milk movement has gained momentum through social media influencers and political campaigns such as the Make America Healthy Again (MAHA) movement, which has advocated for legalizing unpasteurized dairy sales. Notably, Health and Human Services Secretary Robert F. Kennedy Jr. has previously identified as a raw milk enthusiast.

    Dr. Kali Kneil, Professor of Microbial Food Safety at the University of Delaware, cautioned that ‘even if it’s a clean dairy, or the animals look healthy, you cannot guarantee that raw milk is clear of pathogens.’ She attributed the trend’s popularity partly to European studies suggesting raw milk might help with asthma and allergies, though she emphasized that pasteurization doesn’t significantly diminish nutritional value while providing crucial protection.

    Health officials are urging state and local governments to follow New Mexico’s lead in warning vulnerable populations—including pregnant women, young children, elderly individuals, and immunocompromised persons—about the serious risks associated with raw dairy consumption.

  • Nestle recalls more Guigoz baby formula as France tightens toxin level

    Nestle recalls more Guigoz baby formula as France tightens toxin level

    In a significant development for infant nutrition safety, Nestle has broadened its recall of Guigoz-brand baby formula products following France’s decision to implement more stringent regulations regarding cereulide toxin levels. This move contradicts earlier analyst predictions that additional withdrawals would be unnecessary.

    The expanded recall comes as detection methods for cereulide—a toxin known to cause nausea, vomiting, and other gastrointestinal symptoms—have become increasingly sophisticated. The contamination originated from ingredients sourced from a Chinese manufacturing facility that supplies multiple major infant formula producers, including industry giants Danone and Lactalis.

    France’s revised safety threshold, established last Saturday, represents a proactive measure to enhance consumer protection amid growing international concern. The decision followed consultations with the European Food Safety Authority (EFSA), which subsequently issued comparable guidance earlier this week.

    Despite assertions from Barclays and Jefferies analysts that Nestle and Danone would likely avoid further recalls, Nestle proceeded with voluntary market withdrawals. This marks the third recall incident since December, when initial contaminations were identified.

    The situation has gained additional gravity as French authorities investigate potential connections between the contaminated products and the tragic deaths of two infants. While both Nestle and French health officials emphasize that no conclusive evidence currently links the formula to these fatalities, results from ongoing investigations are anticipated within days.

    The contamination event has triggered widespread product recalls across dozens of countries, generating substantial concern among parents and caregivers regarding infant nutrition safety standards and international supply chain oversight.

  • Health warning over Cape Verde travel after stomach bug deaths

    Health warning over Cape Verde travel after stomach bug deaths

    The UK Health Security Agency (UKHSA) has escalated travel health advisories for Cape Verde following a significant outbreak of gastrointestinal infections that have affected British tourists. Official data reveals 118 confirmed cases of shigellosis and 43 instances of salmonella poisoning linked to visits to the West African archipelago since October, with four British nationals having died within months of contracting these illnesses during their holidays.

    This health alert emerges strategically ahead of the February half-term break, a period when substantial numbers of UK travelers traditionally seek winter sun in Cape Verde’s typically warm 25°C climate. Both shigella and salmonella are serious bacterial infections targeting the intestinal system, producing severe symptoms including acute diarrhea, high fever, and abdominal cramps. While most healthy individuals recover within several days, vulnerable populations—particularly young children, elderly adults, pregnant women, and immunocompromised individuals—face potentially life-threatening complications.

    Transmission occurs primarily through fecal-oral routes, either via direct person-to-person contact or indirectly through contaminated food, water, or surfaces. UKHSA epidemiological tracing indicates the majority of shigella cases originated from the Santa Maria resort area on Sal Island and Boa Vista, the archipelago’s easternmost island.

    Medical experts emphasize preventive measures including consuming only freshly prepared, thoroughly cooked foods served hot; drinking bottled or boiled water while avoiding ice; using purified water for dental hygiene; personally peeling all fruits; and avoiding salads potentially washed in contaminated water. Dr. Gauri Godbole, UKHSA’s deputy director for gastrointestinal infections, stressed that ‘taking simple precautions against traveler’s diarrhoea can make all the difference,’ highlighting meticulous hand hygiene with soap or alcohol gel as the primary defense mechanism.

    Professor Damien Tully of the London School of Hygiene and Tropical Medicine noted that such outbreaks are ‘not unusual in busy hospitality settings,’ particularly identifying buffet-style catering as potential ‘breeding grounds’ for pathogens.

    The human impact includes four documented British fatalities in 2023: Mark Ashley (55, Bedfordshire), Elena Walsh (64, Birmingham), Karen Pooley (64, Gloucestershire), and an unnamed 56-year-old Watford man. These individuals are among six British tourists who died after vacationing in Cape Verde since January 2023, with all families now pursuing personal injury litigation against package holiday giant Tui. Relatives have reported concerning hygiene standards at resorts, though Tui has acknowledged investigating these claims while refraining from detailed commentary during active legal proceedings.

    Compounding the situation, Hurricane Erin’s August strike damaged critical water and sanitation infrastructure across Cape Verde, prompting World Health Organization assessments warning of elevated disease risks from contaminated water and insect vectors.

  • WHO announces restart of preventive cholera vaccinations after nearly 4-year halt

    WHO announces restart of preventive cholera vaccinations after nearly 4-year halt

    CAPE TOWN — The World Health Organization announced Wednesday the resumption of preventive cholera vaccination initiatives worldwide, marking a pivotal shift from reactive outbreak response to proactive immunization strategies. This development follows the resolution of a severe vaccine shortage that had paralyzed global prevention efforts for nearly four years.

    In a coordinated declaration, WHO alongside GAVI vaccine alliance and UNICEF revealed that the oral cholera vaccine stockpile has rebounded to approximately 70 million doses—a dramatic recovery from the critically low 35 million doses available during the 2022 shortage crisis. The improved supply enables the first preventive allocation of 20 million doses, with Mozambique receiving 3.6 million doses, Congo obtaining 6.1 million, and Bangladesh scheduled for 10.3 million doses.

    WHO Director-General Tedros Adhanom Ghebreyesus emphasized the strategic importance: “Global vaccine shortages previously confined us to merely reacting to cholera outbreaks. We now possess the capacity to break this cycle through preventive vaccination campaigns.”

    The resurgence of cholera—a waterborne diarrheal disease—has been exacerbated by intersecting crises of poverty, conflict, and climate change. Recent devastating floods in Mozambique affecting 700,000 people exemplify how climate-related disasters amplify cholera risks by compromising water sanitation infrastructure and facilitating bacterial spread.

    During the shortage, WHO implemented a single-dose vaccination protocol as an emergency measure. The organization now maintains this single-dose approach as standard practice, while considering two-dose campaigns based on specific epidemiological circumstances.

    Surveillance data reveals concerning trends: 2023 recorded over 600,000 cholera cases and approximately 7,600 fatalities worldwide. While case numbers showed a decline in 2025 after consecutive annual increases since 2021, cholera-related mortality rates continue to climb, underscoring the critical need for sustained preventive measures.